SLC4A11 and congenital hereditary endothelial dystrophy of cornea: Screening for SLC4A11 variations can help in the differential and confirmative diagnosis of CHED to manage the available corneal transplant options, including Descemet’s membrane endothelial keratoplasty (DMEK) and Descemet’s stripping automated endothelial keratoplasty (DSAEK) [11].